Fig. 6From: The integration of multidisciplinary approaches revealed PTGES3 as a novel drug target for breast cancer treatmentExpression level of PTGES3 in breast cancer and molecular docking analysis. a mRNA expression level in three cohorts. b The mRNA expression level in breast cancer cell lines; c Protein level in breast cancer samples. d Potential drugs targeted PTGES3; Genistein (e), Diethylstilbestrol (f) and Gedunin (g) docked into the PTGES3 crystal structure. h Molecular docking analysis of three drugs. *p < 0.05, **p < 0.01; ***p < 0.005, ****p < 0.001Back to article page